Research on Cancer Proteomics
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Biophysics".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 7470
Special Issue Editor
Interests: cancerogenesis; cancer cells drug resistance; cell signaling in cancer and normal cells; protein kinases in cancerogenesis; proteomics; confocal microscopy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer remains one of the most deadly diseases. Understanding the hallmarks of cancer has already provided some clues for precision drug targeting. On the other hand, conventional cancer therapies that are designed nonspecifically suppress all proliferating cells, including cancerous ones. These therapies are widely applied and apparently will be used in clinics for the foreseen future. Unfortunately, both types of drugs lead to the development of cancer cell drug resistance.
Cell signaling, including receptor tyrosine kinases and protein kinase cascades and their aberrations, cause many pathologies such as cancer. However, its role in drug resistance continues to be underappreciated and understudied, especially in relation to high content information generation techniques such as proteomics.
Proteomics emerges as a powerful tool to study cancerogenesis mechanisms, to find protein markers for cancer detection and individualized treatment, as well as to study mechanisms of drug action. Specific areas of proteomics including interactomes, phosphoproteomes, kinomes, etc., contribute to the field of cancerogenesis and cancer treatment considerably and will continue to perform major roles in the future. However, proteomics’ role in researching drug resistance deserves more focus and efforts.
How can we treat cancer more effectively? How will a fundamental understanding of normal vs cancerous cell signaling facilitate cancer therapy? What are cancerogenesis molecular mechanisms and how they might be targeted? These and similar questions will have to be addressed and answered to make sustainable breakthroughs in cancer treatment.
In this Special Issue of Cells, we welcome researchers to submit their existing findings on cancerogenesis mechanisms, cell signaling, and proteomics related to cancer treatment and drug resistance.
We look forward for your contribution to this intensely developing area of research.
Dr. Mindaugas Valius
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Cancerogenesis
- cancer therapy resistance
- cell signaling
- protein kinases
- proteomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
